4 completed. 2 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow ISV-303: new trials by email Literature Review of ISV-303 trials Research Report on ISV-303
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects ISV-303, DuraSite Vehicle - Ocular Inflammation | Phase 3 | Completed | Sun Pharmaceutical Industries Limited | 268 | 2013-05-01 | 2021-11-19 |
| Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects ISV-303, DuraSite Vehicle - Ocular Inflammation | Phase 3 | Completed | Sun Pharmaceutical Industries Limited | 268 | 2012-07-01 | 2021-11-19 |
| Aqueous Humor Concentration of InSite Vision (ISV) 303 (Bromfenac in DuraSite) to Bromday Once Daily (QD) Prior to Cataract Surgery ISV-303, Bromday™ - Cataract | Phase 2 | Completed | Sun Pharmaceutical Industries Limited | 60 | 2011-07-01 | 2021-11-19 |
| Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers ISV-303, DuraSite Vehicle, Xibrom™ - Ocular Inflammation | Phase 1 / Phase 2 | Completed | Sun Pharmaceutical Industries Limited | 169 | 2010-08-01 | 2021-11-19 |
Cataract (1)
Sun Pharmaceutical Industries Limited (4)